Dr. Tina Z. Wang, MD, MS

Dr. Wang practices at Columbia University Irving Medical Center in New York, New York.

Dr. Wang's NPI, 1487071734, was assigned on March 25, 2014. Dr. Wang graduated from University Of Michigan Medical School in 2014. Dr. Wang holds New York license 295277.

Dr. Wang's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Wang's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Wang is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Wang to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Wang is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Wang's licenses on file in 4 states: New York, Florida, New Jersey and Connecticut.

Dmand AI lists hiv/aids, pneumonia, sepsis and UTI among the conditions Dr. Wang treats.

CMS data shows 92 Medicare services from Dr. Wang across 3 procedure codes in 2023, for 28 Medicare patients. Medicare paid $9,257 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 15 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 61% are also on Medicaid. Their average risk score is 4.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 57, with 40% women.

In 2024, Dr. Wang wrote 39 Medicare Part D claims. 51% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $44,247 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wang for performance year 2024, reported through an alternative payment model (APM). Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 6 papers to Dr. Wang, published from 2019 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents and Bacterial Infections. Dr. Wang's most frequent co-authors are Sigurd Harald Berven, MD, Christopher M. Bonfield, MD and Ian Andre Buchanan, MD.

Dmand AI links Dr. Wang to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 2 general payments to Dr. Wang from 2 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $114.

Dr. Wang graduated from University Of Michigan Medical School in 2014.

Dr. Wang is in network with 12 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.